NCT06761599 is a clinical trial of group 1 in Hodgkin Lymphoma, sponsored by Superior University.

Who is sponsoring NCT06761599?

NCT06761599 is sponsored by Superior University.

What drugs are being tested in NCT06761599?

Interventions in NCT06761599: group 1.

What condition does NCT06761599 study?

NCT06761599 studies Hodgkin Lymphoma.

Is NCT06761599 still recruiting?

NCT06761599 is currently active, enrolled. Last updated 7 January 2025.

Last reviewed 2025-01-07 · How we verify

NCT06761599

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Frequency of Pulmonary Toxicity in Patients Treated for Hodgkin Lymphoma

Active, enrolled Last updated 7 January 2025

What this trial tests

trial testing group 1 in Hodgkin Lymphoma in 214 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

18 February 2024

Primary endpoint
15 July 2024

1 March 2025

Quick facts

Lead sponsor	Superior University
Status	Active, enrolled
Study type	OBSERVATIONAL
Enrollment	214
Start date	18 February 2024
Primary completion	15 July 2024
Estimated completion	1 March 2025
Sites	1 location across Pakistan

Drugs / interventions tested

group 1

Conditions studied

Hodgkin Lymphoma — all drugs for Hodgkin Lymphoma →

Sponsor

Superior University

Who can join

18 and older, any sex, with Hodgkin Lymphoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Pulmonary toxicity during Hodgkin lymphoma treatment is significant for a variety of reasons, ranging from clinical care to therapeutic innovation and patient outcomes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of group 1

Trials testing the same drug.

NCT06749535 — The Detection of Chronic Obstructive Pulmonary Disease in Patients With Diabetes Mellitus · active not recruiting
NCT06748768 — The Effect of Omega 3 Supplements Comparison With Warm Compression in Patients With Dry Eye Disease · active not recruiting
NCT06748794 — Effects of Intrathecal Midazolam (1mg) With Hyperbaric Bupivacaine 0.5% (15mg) for Spinal Anesthesia for C-section · active not recruiting
NCT05786326 — Multihole Fully Covered Metallic Stents in the Management of Malignant Biliary Obstruction · NA · completed

Other recruiting trials for Hodgkin Lymphoma

Currently open trials in the same condition.

NCT07020533 — A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Pa · Phase 1 · recruiting
NCT07566377 — Cord Blood Transplantation in Children and Young Adults With Blood Cancer · Phase 2 · recruiting
NCT07285044 — The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Tr · Phase 2 · recruiting
NCT06176690 — Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas · Phase 1 · recruiting
NCT07002216 — BrECADD Therapy in Stage 2 B-IV Hodgkin Lymphoma · Phase 2 · recruiting

Other Superior University trials

Trials by the same sponsor.

NCT07521839 — Title of This Study is to Evaluate the Effects of Abdominal Drawing in Maneuver With Cross Pattern Limb Exercises in Pat · NA · active not recruiting
NCT07523425 — Collaborative vs Non-Immersive VR in Parkinson's Rehabilitation · NA · recruiting
NCT07068347 — Comparison Of VR & CPT, With And Without Lifestyle Modification, On ULD In Breast Cancer Survivors · NA · active not recruiting
NCT07336459 — AI-Driven MRF Type 2 Diabetes Integrating DHT IF and Resistance Training to OM and Functional Outcomes · NA · active not recruiting
NCT07385066 — Effects of (tDCS) Combined With Virtual Reality Versus CPT on Brain, Cognitive, and GMS in Children With DS. · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06761599 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Superior University
Last refreshed: 7 January 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06761599.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing